UBS Group’s Nuveen Real Asset Income & Growth Fund JRI Stock Holding History

UBS Group’s Portfolio JRI Stock Details JRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$577K	Sell	46,889 -21,298	-31%	-$277K	﹤0.01%	5984
2025 Q4	$928K	Sell	68,187 -1,937	-3%	-$26.6K	﹤0.01%	5645
2025 Q3	$999K	Sell	70,124 -65,390	-48%	-$884K	﹤0.01%	5574
2025 Q2	$1.83M	Buy	135,514 +54,112	+66%	+$691K	﹤0.01%	4914
2025 Q1	$1.05M	Sell	81,402 -34,906	-30%	-$444K	﹤0.01%	5251
2024 Q4	$1.41M	Buy	116,308 +17,808	+18%	+$233K	﹤0.01%	5035
2024 Q3	$1.35M	Buy	98,500 +11,057	+13%	+$141K	﹤0.01%	4370
2024 Q2	$1.06M	Sell	87,443 -28,955	-25%	-$335K	﹤0.01%	4367
2024 Q1	$1.38M	Sell	116,398 -36,660	-24%	-$426K	﹤0.01%	4317
2023 Q4	$1.79M	Sell	153,058 -2,963	-2%	-$31.9K	﹤0.01%	3946
2023 Q3	$1.66M	Sell	156,021 -43,052	-22%	-$483K	﹤0.01%	3625
2023 Q2	$2.27M	Buy	199,073 +7,110	+4%	+$81.2K	﹤0.01%	3400
2023 Q1	$2.25M	Buy	191,963 +60,090	+46%	+$728K	﹤0.01%	3291
2022 Q4	$1.54M	Sell	131,873 -36,407	-22%	-$423K	﹤0.01%	3643
2022 Q3	$1.88M	Sell	168,280 -15,733	-9%	-$208K	﹤0.01%	3213
2022 Q2	$2.4M	Buy	184,013 +999	+0.5%	+$14.1K	﹤0.01%	2989
2022 Q1	$2.8M	Sell	183,014 -85	-0%	-$1.28K	﹤0.01%	3112
2021 Q4	$2.95M	Buy	183,099 +7,502	+4%	+$117K	﹤0.01%	3370
2021 Q3	$2.68M	Buy	175,597 +16,554	+10%	+$264K	﹤0.01%	3324
2021 Q2	$2.56M	Buy	159,043 +67,541	+74%	+$1.06M	﹤0.01%	3346
2021 Q1	$1.35M	Buy	91,502 +485	+0.5%	+$6.82K	﹤0.01%	3951
2020 Q4	$1.23M	Sell	91,017 -36,292	-29%	-$462K	﹤0.01%	3851
2020 Q3	$1.53M	Sell	127,309 -9,191	-7%	-$111K	﹤0.01%	3308
2020 Q2	$1.59M	Sell	136,500 -5,243	-4%	-$58.2K	﹤0.01%	3095
2020 Q1	$1.4M	Buy	141,743 +7,649	+6%	+$124K	﹤0.01%	3079
2019 Q4	$2.46M	Buy	134,094 +4,517	+3%	+$80.7K	﹤0.01%	3338
2019 Q3	$2.27M	Buy	129,577 +4,031	+3%	+$68.4K	﹤0.01%	3169
2019 Q2	$2.13M	Buy	125,546 +15,911	+15%	+$258K	﹤0.01%	3091
2019 Q1	$1.76M	Sell	109,635 -286,043	-72%	-$4.4M	﹤0.01%	3100
2018 Q4	$5.39M	Sell	395,678 -37,696	-9%	-$558K	﹤0.01%	2081
2018 Q3	$6.98M	Buy	433,374 +9,060	+2%	+$148K	﹤0.01%	2068
2018 Q2	$6.86M	Sell	424,314 -1,768	-0.4%	-$28.8K	﹤0.01%	2064
2018 Q1	$6.91M	Buy	426,082 +276,978	+186%	+$4.69M	﹤0.01%	2016
2017 Q4	$2.65M	Buy	149,104 +11,367	+8%	+$202K	﹤0.01%	2943
2017 Q3	$2.48M	Buy	137,737 +118,225	+606%	+$2.13M	﹤0.01%	2931
2017 Q2	$343K	Sell	19,512 -574	-3%	-$10K	﹤0.01%	4391
2017 Q1	$346K	Buy	20,086 +1,052	+6%	+$17.7K	﹤0.01%	4291
2016 Q4	$300K	Sell	19,034 -4,602	-19%	-$74.1K	﹤0.01%	4484
2016 Q3	$407K	Buy	23,636 +8,870	+60%	+$154K	﹤0.01%	4052
2016 Q2	$250K	Buy	14,766 +537	+4%	+$8.5K	﹤0.01%	4401
2016 Q1	$219K	Buy	14,229 +2,577	+22%	+$36.8K	﹤0.01%	4427
2015 Q4	$178K	Sell	11,652 -9,978	-46%	-$158K	﹤0.01%	4766
2015 Q3	$318K	Sell	21,630 -1,982	-8%	-$33.1K	﹤0.01%	4261
2015 Q2	$408K	Buy	23,612 +2,751	+13%	+$52.3K	﹤0.01%	4289
2015 Q1	$407K	Sell	20,861 -137	-0.7%	-$2.65K	﹤0.01%	4307
2014 Q4	$396K	Buy	+20,998	New	+$415K	﹤0.01%	4391

Other funds holding JRI

SIA

Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

AIA

Absolute Investment Advisers Rosemary Beach, Florida $1.03B AUM 1% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group's JRI Position: Q1 2026 in Review

UBS Group reduced its Nuveen Real Asset Income & Growth Fund (JRI) stake by 31% in Q1 2026, selling an estimated $277K and leaving 46,889 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #5984.

UBS Group first reported a position in JRI in Q4 2014 and has held it in 46 quarters since. The position peaked at $6.98M in Q3 2018. 91 funds tracked by Wall St. Rank hold JRI as of Q1 2026.

UBS Group held 46,889 shares of Nuveen Real Asset Income & Growth Fund worth $577K as of Q1 2026.
UBS Group sold 21,298 Nuveen Real Asset Income & Growth Fund shares in Q1 2026, an estimated $277K.
Nuveen Real Asset Income & Growth Fund made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5984 holding.
UBS Group first reported a position in Nuveen Real Asset Income & Growth Fund in Q4 2014 and has held it in 46 quarters since.
UBS Group's Nuveen Real Asset Income & Growth Fund position peaked at $6.98M in Q3 2018.
91 funds tracked by Wall St. Rank held Nuveen Real Asset Income & Growth Fund as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.